Results 271 to 280 of about 15,529,870 (301)

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

MR1 antigen presentation to MAIT cells and other MR1-restricted T cells

Nature Reviews Immunology, 2023
Jose A. Villadangos, Hamish E McWilliam
exaly  

GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity

Cancer Cell, 2022
Kevin R. Parker, Anya Alag, Crystal Mackall   +2 more
exaly  

[Chemistry, toxicity and antigenicity of O antigen].

Hoppe-Seyler's Zeitschrift fur physiologische Chemie, 2002
Y, TAKEDA, N, KASAI, M, ARAKI, T, ODAKA
openaire   +1 more source

Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors

Cancer Cell, 2020
Vid Leko, Steven Rosenberg
exaly  

O Antigen

2008
openaire   +1 more source

[On the immunochemistry of the O antigens of Enterobacteriaceae. V. The antigen factors in isolated Salmonella O antigens].

Biochemische Zeitschrift, 1998
O, LUEDERITZ, G, O'NEILL, O, WESTPHAL
openaire   +1 more source

Prostate-specific antigen: Current status†

Ca-A Cancer Journal for Clinicians, 1999
Michael K Brawer, M K Brawer
exaly  

Prostate-specific antigen and premalignant change: Implications for early detection

Ca-A Cancer Journal for Clinicians, 1989
Michael K Brawer, M K Brawer, Paul H Lange   +2 more
exaly  

How to use prostate-specific antigen in the early detection orscreening for prostatic carcinoma

Ca-A Cancer Journal for Clinicians, 1995
Michael K Brawer, M K Brawer
exaly